Article Information
- Received June 27, 2011
- Revision received August 29, 2011
- Accepted August 31, 2011
- First published October 26, 2011.
- Version of record published October 26, 2011.
Author Information
- Leonardo Almeida-Souza1,
- Bob Asselbergh1,
- Constantin d'Ydewalle2,
- Kristof Moonens3,
- Sofie Goethals1,
- Vicky de Winter1,
- Abdelkrim Azmi4,
- Joy Irobi1,
- Jean-Pierre Timmermans5,
- Kris Gevaert6,
- Han Remaut3,
- Ludo Van Den Bosch2,
- Vincent Timmerman1, and
- Sophie Janssens1,7
- 1Peripheral Neuropathy Group, Department of Molecular Genetics, VIB and University of Antwerp, Antwerp 2610, Belgium,
- 2Laboratory for Neurobiology, Vesalius Research Center, VIB and University of Leuven, Leuven 3000, Belgium,
- 3Laboratory for Structural and Molecular Microbiology, VIB Department of Cellular and Molecular Interactions, Vrije Universiteit Brussel, Brussels 1050, Belgium,
- 4Centre for Proteome Analysis and Mass Spectrometry, Department of Biology, and
- 5Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Antwerp 2020, Belgium,
- 6Department of Medical Protein Research, VIB and Department of Biochemistry, Ghent University, Ghent 9000, Belgium, and
- 7GROUP-ID Consortium, Laboratory for Immunoregulation and Mucosal Immunology, Department of Pulmonary Medicine, University Hospital of Ghent, Ghent 9000, Belgium
Author contributions
Author contributions: L.A.-S., B.A., C.d'Y., H.R., L.V.D.B., V.T., and S.J. designed research; L.A.-S., B.A., C.d'Y., K.M., S.G., V.d.W., A.A., and K.G. performed research; J.I. and J.-P.T. contributed unpublished reagents/analytic tools; L.A.-S., B.A., C.d'Y., K.M., A.A., K.G., H.R., and S.J. analyzed data; L.A.-S. and S.J. wrote the paper.
Disclosures
- Received June 27, 2011.
- Revision received August 29, 2011.
- Accepted August 31, 2011.
This work was supported in part by the Methusalem program of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth, the “Association Belge contre les Maladies Neuromusculaires,” the American Muscular Dystrophy Association, the Hercules Foundation (providing funding for live cell imaging equipment), and the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office. C.d'Y. and K.M. are supported by a PhD Fellowship of the Institute for Science and Technology and FWO-Flanders, respectively. S.J. and J.I. are postdoctoral researchers supported by the FWO-Flanders. H.R. is supported by a VIB PRJ Grant and the Odysseus program of the FWO-Flanders. We are grateful to A. Jacobs for technical assistance and E. Timmerman for the LC-MS/MS analyses. We also thank the VIB Protein Service Facility for recombinant protein production and the VIB Genetic Service Facility for sequencing support.
- Correspondence should be addressed to either Vincent Timmerman or Sophie Janssens, Peripheral Neuropathy Group, VIB Department of Molecular Genetics, University of Antwerp, Universiteitsplein 1, 2610 Antwerpen, Belgium, vincent.timmerman{at}molgen.vib-ua.be or sophie.janssens{at}ugent.be
Online Impact